Onderzoeker
Dirk Hose
- Trefwoorden:Geneeskunde
Affiliaties
- Hematologie (Onderzoeksgroep)
Lid
Vanaf22 mrt 2021 → Heden - Basis (bio)-medische wetenschappen (Departement)
Lid
Vanaf1 mrt 2020 → Heden - Basis (bio)-medische wetenschappen (Departement)
Lid
Vanaf1 mrt 2020 → 20 okt 2022
Publicaties
1 - 10 van 109
- RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma(2023)
Auteurs: Martina Emde-Rajaratnam, Susanne Beck, Vladimir Benes, Hans Jürgen Salwender, Uta Bertsch, Christoph Scheid, Mathias Hänel, Katja Weisel, Thomas Hielscher, Marc S Raab, et al.
- Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma(2023)
Auteurs: Rong Fan, Hatice Satilmis, Niels Vandewalle, Emma Verheye, Philip Vlummens, Anke Maes, Catharina Muylaert, Elke De Bruyne, Eline Menu, Holly Evans, et al.
- Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma(2023)
Auteurs: Elias K Mai, Stefanie Huhn, Kaya Miah, Alexandra M Poos, Christof Scheid, Katja C Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, et al.
- Patient and Caregiver Experience Decision Factors in Treatment Decision Making-Results of a Systematic Literature Review of Multiple Myeloma Decision Aids(2023)
Auteurs: Mimi Choon-Quinones, Dirk Hose, Zoltán Kaló, Tamás Zelei, Jean-Luc Harousseau, Brian Durie, Paul Keown, Mike Barnett, Ivett Jakab
Pagina's: 39-49 - Systematic literature review of health economic models developed for multiple myeloma to support future analyses(2023)
Auteurs: Mimi Choon-Quinones, Tamás Zelei, Bertalan Németh, Manna Tóth, Xiao Yang Jia, Mike Barnett, Paul Keown, Brian Durie, Jean-Luc Harousseau, Dirk Hose, et al.
Pagina's: 110-119 - The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistance(2022)
Auteurs: Sara Ovejero, Elena Viziteu, Laure Dutrieux, Julie Devin, Yea-Lih Lin, Elina Alaterre, Michel Jourdan, Jihane Basbous, Guilhem Requirand, Nicolas Robert, et al.
- Resemblance-Ranking Peptide Library to Screen for Binders to Antibodies on a Peptidomic Scale(2022)
Auteurs: Felix Jenne, Sergey Biniaminov, Nathalie Biniaminov, Philipp Marquardt, Clemens von Bojničić-Kninski, Roman Popov, Anja Seckinger, Dirk Hose, Alexander Nesterov-Mueller
- Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis(2022)
Auteurs: Inge Oudaert, Hatice Satilmis, Philip Vlummens, Wouter De Brouwer, Anke Maes, Dirk Hose, Elke De Bruyne, Bart Ghesquière, Karin Vanderkerken, Kim De Veirman, et al.
Pagina's: 45 - MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma(2022)
Auteurs: Jacob Stroh, Anja Seckinger, Michael Heider, Martina Rudelius, Ruth Eichner, Markus Schick, Jolanta Slawska, Martina Emde-Rajaratnam, Hans J Salwender, Uta Bertsch, et al.
Pagina's: 515-520 - Beyond medicines' barriers(2022)
Auteurs: Mimi Choon-Quinones, Tamás Zelei, Mike Barnett, Paul Keown, Brian Durie, Zoltán Kaló, Tímea Almási, Jean-Luc Harousseau, Dirk Hose
Pagina's: 1167-1175